Ironwood Pharmaceuticals buy Wells Fargo & Company
Start price
14.12.23
/
50%
€10.20
Target price
14.12.24
€18.27
Performance (%)
-40.20%
Price
01.08.24
€6.15
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals is performing very badly with a performance of -40.20%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ironwood Pharmaceuticals | -0.806% | -0.806% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ironwood Pharmaceuticals diskutieren
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for IRWD provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Start price
Target price
Perf. (%)
€8.40
01.03.24
01.03.24
€12.91
01.03.25
01.03.25
-27.38%
01.08.24
01.08.24